FDA Inspection
VitalantVitalant – FDA Inspection, Jun 9, 2026
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on June 9, 2026, issued by the Minneapolis District Office, covering biologics.
- Person
View Company Profile
ID · da5e8ab1-63da-412f-85c8-74271469ac14
Inspection Facts
- Inspection number
- 1321216
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 10, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 25, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 20, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 30, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 9, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1178692 - 2022-08-10
- FDA Inspection 1063370 - 2018-07-25
- FDA Inspection 971653 - 2016-04-20
- FDA Inspection 878175 - 2014-04-30
- FDA Inspection 779317 - 2012-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.